EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

Supplies of medicines could be disrupted when UK leaves EU says Brexit Health Alliance

Patients could find that supplies of their medicines will be disrupted when the UK leaves the EU,  according to the Brexit Health Alliance in a briefing paper publish...
Continue Reading →
Europe

Arran Chemical Company Completes First Phase of its Three Part Strategic Plan “ADAPT” Multimillion Euro Expansion of Manufacturing Capacity and Growth of Next Generation Production Technology Portfolio

Irish based Arran Chemical Company has responded to client demand for provision of fine chemicals, pharmaceutical intermediates and advanced building blocks by implem...
Continue Reading →
Europe

Pharma Publications at CPhI Worldwide 2017

  The international pharmaceutical networking exhibition, CPhI Worldwide 2017, is being held in Messe Frankfurt from the 24th to the 26th of October 2017. Over 2...
Continue Reading →
Europe

Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent®(alirocumab)

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent in...
Continue Reading →
Asia Pacific

AMRI names Joseph D. Sangregorio SVP and chief human resources officer

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life f...
Continue Reading →
Europe

New artificial skin trials offer hope to acid attack victims

  The horrific increase in the number of acid attacks in the UK has given medical research trust RAFT even more reason to back its latest next generation artifi...
Continue Reading →
Europe

Amgen and CytomX Therapeutics announce strategic collaboration in immuno-oncology

Amgen (NASDAQ:AMGN) and CytomX Therapeutics, Inc., (NASDAQ:CTMX) today announced that the companies have entered into a strategic collaboration in immuno-oncology. Th...
Continue Reading →
Europe

Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies

 Immatics, a leading company in the field of cancer immunotherapy, today announced the completion of its Series E financing, raising $58 million. The Series E funding...
Continue Reading →
Europe

After Prostvac flop, Bavarian Nordic showcases 6-month RSV data

Bavarian Nordic is ready to turn the page after its key cancer vaccine candidate Prostvac failed a phase 3 study, wiping off half its share price. The vaccine special...
Continue Reading →
Europe

SIRION Biotech and Vibalogics partner to offer complete Adeno-Associated Virus (AAV) services

Munich, Germany - SIRION Biotech GmbH and Vibalogics GmbH, have signed a strategic partnership agreement designed to meet demand from gene therapy companies for a sta...
Continue Reading →
Quotient